Boardroom Alpha
Meeting calendar
SENEA · Special meeting · Wednesday, November 4, 2026

Seneca Foods Corp

3 ballot items.

Shareholders will vote on a five-for-one forward stock split with related capital-stock adjustments, removal of the authorized Preferred Stock Without Par Value, and any other business properly brought before the Special Meeting.

Market cap
$975M
1Y TSR
+43.9%
Board grade
A-
Record date
Sep 14, 2026
Filing
DEF 14A
Meeting concluded · Nov 4, 2026

Follow how the vote landed and what changed on Seneca Foods Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Approval to Effect a Forward Five-for-One Stock Split

    ManagementBoard: FOR

    Approve an amendment to the Restated Certificate of Incorporation to effect a five-for-one forward stock split, proportionately increase authorized capital stock, reduce the par value of specified common and preferred stock, and reduce the stated value, dividend rate, redemption price, and conversion price of designated Class A Preferred Stock series.

    More detail

    Proposal 1 asks shareholders to approve an amendment implementing a five-for-one forward split of the Company’s outstanding Common Stock and specified preferred stock. The amendment would increase the authorized shares of Class A Common Stock from 20 million to 100 million and Class B Common Stock from 10 million to 50 million, with corresponding increases for specified preferred stock classes and series. It would reduce the par value of the common stock and 6% Preferred Stock from $0.25 to $0.05 per share. It would also proportionately reduce the stated values, dividend rates, redemption prices, and conversion price applicable to the designated preferred stock so aggregate economic rights and conversion ratios remain substantially unchanged. The Company states that its Common Stock price has risen significantly and that the split is intended to make the shares more accessible to current and prospective investors and support market liquidity. Because the Certificate requires both common-stock classes to be split proportionally, the transaction applies equally to Class A and Class B Common Stock. The proposal is conditioned on approval of Proposal 2, and neither amendment will be adopted unless both amendments are approved. The Board also notes that the authorized-share increase could have anti-takeover implications, but states that the proposal is not being made in response to any effort to accumulate stock or obtain control. The Board unanimously recommends voting FOR the proposal and reserves discretion not to proceed before filing if it later determines the transaction is no longer in the Company’s or shareholders’ best interests.

  2. 2

    Approval to Remove the Preferred Stock Without Par Value from the Authorized Shares of the Company

    ManagementBoard: FOR

    Approve an amendment deleting the Certificate provision authorizing 30,000 shares of Preferred Stock Without Par Value, a class for which no series has been designated and no shares have been issued.

    More detail

    Proposal 2 asks shareholders to amend the Restated Certificate of Incorporation to eliminate the authorized Preferred Stock Without Par Value. The current Certificate authorizes 30,000 shares of this class and permits the Board to issue the shares in series subject to legal limitations. The Company states that the Board has never designated a series of this class. It also states that no shares of the Preferred Stock Without Par Value have ever been issued. Approval would delete Section (c) of Article 4 in its entirety and remove related references elsewhere in the Certificate. The proposal is primarily a capitalization-cleanup measure because the unused class has no current holders or outstanding economic rights. It is linked to Proposal 1 because both Proposed Amendments must be approved before either can be adopted. The Company expects to file the amendments promptly after the Special Meeting if shareholders approve them and the Board elects to proceed. The Board unanimously approved and declared the amendment advisable. The Board unanimously recommends that shareholders vote FOR Proposal 2.

  3. 3

    Other Business

    Management

    Transact such other business as may properly come before the Special Meeting.

    More detail

    Proposal 3 is a customary authorization covering any other business properly brought before the Special Meeting. The Company states that it does not know of any additional matters expected to be presented. If another matter is properly presented, the persons designated as proxies may vote the represented shares in accordance with their judgment. This item is not a request for approval of a specifically identified corporate action. It gives proxy holders discretionary authority for unforeseen matters that satisfy the meeting’s procedural requirements. The filing does not identify a separate substantive recommendation from the Board for this item. Shares held in street name may not be voted by a broker on other business unless the broker receives shareholder instructions. The proposal therefore functions as a procedural catch-all rather than an independent transaction or governance change. No shareholder proponent is identified. The proxy statement’s substantive recommendations are limited to voting FOR Proposals 1 and 2.

Director elections

Nominees on the ballot

Nominee list not yet available for this filing.
Ownership

Top institutional holders10

Latest 13F quarter
1DIMENSIONAL FUND ADVISORS LP6.1%410,064$71M
2AMERICAN CENTURY COMPANIES INC4.3%291,319$51M
3ALLIANCEBERNSTEIN L.P.3.0%203,539$31M
4VANGUARD CAPITAL MANAGEMENT LLC2.9%197,665$34M
5BlackRock, Inc.2.9%195,131$34M
6VANGUARD PORTFOLIO MANAGEMENT LLC2.8%187,688$33M
7BlackRock, Inc.2.4%159,469$28M
8GEODE CAPITAL MANAGEMENT, LLC2.1%140,822$24M
9STATE STREET CORP1.9%127,248$22M
10CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.3%87,317$15M
Filings

Seneca Foods Corp proxy statements and SEC reports

Annual & quarterly reports (10-K, 10-Q)
Proxy statements (DEF 14A)
Reference

Frequently asked questions

When is the Seneca Foods Corp 2026 special meeting?
Seneca Foods Corp (SENEA) holds its 2026 special shareholder meeting on Wednesday, November 4, 2026.
What is the record date for the Seneca Foods Corp 2026 meeting?
The record date for the Seneca Foods Corp 2026 meeting is Monday, September 14, 2026. Shareholders of record on or before that date are eligible to vote.
What proposals will shareholders vote on at the Seneca Foods Corp 2026 meeting?
Shareholders will vote on 3 proposals at the Seneca Foods Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer